Rate control versus rhythm control - Decision making

Canadian Journal of Cardiology

Volumn 21, Issue SUPPL. B, 2005, Pages

  Wyse, D George ^a   Simpson, Christopher S ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Atrial fibrillation; Rate control; Rhythm control; Rhythm management

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONFERENCE PAPER; DECISION MAKING; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HUMAN; PRACTICE GUIDELINE; SINUS RHYTHM;

ATRIAL FIBRILLATION; CLINICAL TRIALS; HEART RATE; HUMANS; PRACTICE GUIDELINES;

EID: 27144525106     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Miller MR, McNamara RL, Segal JB, et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: A meta-analysis of clinical trials. J Fam Pract 2000;49:1033-46.
2. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990;82:1106-16.
3. (Erratum in 1991;83:714).
4. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 1992;20:527-32.
5. Connolly SJ. Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts. Am Heart J 2003;145:418-23.
6. The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation. Atrial fibrillation: Current understandings and research imperatives. J Am Coll Cardiol 1993;22:1830-4.
7. Wyse DG. Rhythm versus rate control trials in atrial fibrillation. J Cardiovasc Electrophysiol 2003;14(Suppl 9):S35-9.
8. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) Trial. Am Heart J 2002;144:597-607.
9. Yamashita T, Ogawa S, Aizawa Y, et al; J-RHYTHM Investigators. Investigation of the optimal treatment strategy for atrial fibrillation in Japan. Circ J 2003;67:738-41.
10. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacologic Intervention in Atrial Fibrillation (PIAF): A randomized trial. Lancet 2000;356:1789-94.
11. The AFFIRM Investigators. Effect of rate-control versus rhythm-contol strategies on the functional status of patients in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. J Am Coll Cardiol 2005. (In press)
12. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators. Atrial fibrillation follow-up investigation of rhythm management - the AFFIRM study design. Am J Cardiol 1997;79:1198-202.
13. AFFIRM Investigators. Atrial Fibrillation Follow-up Investigation of Rhythm Management. Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study. Am Heart J 2002;143:991-1001.
14. Rostagno C, Bacci F, Martelli M, Naldoni A, Bertini G, Gensini G. Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episode. Am J Cardiol 1995;76:837-9.
15. Kerr CR, Humphries KH, Talajic M, et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005;149:489-96.
16. Brignole M, Menozzi C, Gasparini M, et al; PAF 2 Study Investigators. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 2002;23:892-900.
17. Curtis AB, Gersh BJ, Corley SD, et al; AFFIRM Investigators. Clinical factors that influence response to treatment strategies in atrial fibrillation: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:645-9
18. Van Gelder IC, Hagens VE, Bosker HA, et al; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40.
19. Curtis AB, Seals AA, Safford RE, et al. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study. Am Heart J 2005;149:304-8.
20. Fuster V, Ryden LE, Asinger RW, et al; American College of Cardiology; American Heart Association; European Society of Cardiology; North American Society of Pacing and Electrophysiology. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001;22:1852-923.
21. Snow V, Weiss KB, LeFevre M, et al; AAFP Panel on Atrial Fibrillation; ACP Panel on Atrial Fibrillation. Management of newly detected atrial fibrillation: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2003;139:1009-17.